Browse Related Topics For:

Pharmaceutical Industry The United States Food and Drug Administration

350
Prescription Drugs
196
Biosimilars
183
Generic Drugs
162
Patents
154
Medical Devices
149
Pharmaceutical Patents
105
Off-Label Promotion
103
BPCIA
101
Patent Litigation
100
ANDA
100
Patent Infringement
90
Healthcare
86
Biologics
79
FDCA
75
Hatch-Waxman
74
First Amendment
62
Sandoz
61
Amgen
60
Labeling
58
Popular
57
Off-Label Use
56
Manufacturers
52
Draft Guidance
49
Sandoz v Amgen
45
Amarin
41
SCOTUS
40
HHS
40
Preemption
39
Clinical Trials
39
FDA Approval
37
Life Sciences
36
Free Speech
36
Medicare
33
Affordable Care Act
32
FTC
32
Medicaid
31
Marketing
31
Misbranding
30
21st Century Cures Initiative
29
Advertising
29
Preliminary Injunctions
28
Failure To Warn
27
Drug Compounding
27
Pharmacies
25
Health Care Providers
25
Warning Labels
24
CMS
24
Commercial Speech
23
Appeals
21
Biotechnology
20
False Claims Act (FCA)
20
Patent-in-Suit
20
Product Labels
19
DOJ
19
Enforcement Actions
19
Medical Research
19
NIH
19
Patent Dance
18
Commercial Marketing
18
Drug Safety
17
aBLA
17
Comment Period
17
Drug Pricing
17
Physicians
16
AbbVie
16
Apotex
16
Biologics Price Competition and Innovation Act of 2009
16
Orphan Drugs
16
Trump Administration
15
Caronia
15
Citizen Petitions
15
Class Action
15
EU
15
Mylan Pharmaceuticals
15
Safe Harbors
14
Antitrust Litigation
14
Corporate Counsel
14
Final Rules
14
Hospitals
14
New Guidance
14
Patent Applications
14
Social Media
13
DSCSA
13
FFDCA
13
Final Guidance
13
Healthcare Reform
13
Johnson & Johnson
13
PHRMA
13
Reverse Payment Settlement Agreements
13
Settlement
13
Summary Judgment
12
Notice Requirements
12
OIG
12
Proposed Regulation
12
Public Health Service Act
12
Teva Pharmaceuticals
11
Bayer
11
Declaratory Judgments
11
DQSA
11
GlaxoSmithKline
11
Hospira
11
Legislative Agendas
11
Research and Development
11
SEC
11
Supply Chain
11
Warning Letters
10
Discovery
10
Enforcement
10
FTC v Actavis
10
HIPAA
10
Innovation
10
Intellectual Property Protection
10
Multidistrict Litigation
10
Obviousness
10
PLIVA v Mensing
10
Product Exclusivity
10
Professional Conferences
9
Civil Monetary Penalty
9
Drug Approvals
9
Fraud
9
Health Insurance
9
Pending Legislation
9
Personal Jurisdiction
9
Pfizer
9
Prior Art
9
Proposed Legislation
9
Public Comment
9
Public Meetings
9
Reporting Requirements
9
Social Networks
9
USPTO
8
21st Century Cures Act
8
3D Printing
8
Actavis Inc.
8
Antitrust Violations
8
Criminal Prosecution
8
Design Defects
8
Drug Distribution
8
False Advertising
8
Medicare Part D
8
Misleading Statements
8
Orange Book
8
Qui Tam
8
REMS
8
Section 340B
8
Trademarks
8
Whistleblowers
7
Adverse Events
7
Cancer
7
CDC
7
Congressional Investigations & Hearings
7
Cybersecurity
7
Disclosure Requirements
7
European Medicines Agency (EMA)
7
HRSA
7
Inter Partes Review (IPR) Proceeding
7
Janssen Pharmaceuticals
7
Merck
7
Motion to Dismiss
7
Negligence
7
Opioid
7
Patent Invalidity
7
Pay-For-Delay
7
PHSA
7
Product Defects
7
Product Hopping
7
Public Health
7
Public Hearing
7
Side Effects
7
Watson Pharmaceuticals
6
Abbott Laboratories
6
Administrative Procedure Act
6
Barack Obama
6
Birth Defects
6
Black Box Warnings
6
Certiorari
6
Compliance
6
Expert Testimony
6
Federal Funding
6
Federal Rules of Civil Procedure
6
FOIA
6
GAO
6
Health Information Technologies
6
Informed Consent
6
Interchangeability
6
Novartis
6
OMB
6
Otsuka Pharmaceutical
6
Pleading Standards
6
Product Recalls
6
Regulatory Oversight
6
Regulatory Standards
6
Scientific Research
6
Securities Fraud
6
Sherman Act
6
Standing
6
Websites
6
World Health Organization
5
Allergan Inc
5
Anti-Competitive
5
Anti-Kickback Statute
5
Brand
5
Canada
5
Causation
5
CHIP
5
Competition
5
DEA
5
Diagnostic Tests
5
Eli Lilly
5
Exclusivity
5
Federal Rule 12(b)(6)
5
Fifth Amendment
5
HCEI
5
Illegal Drugs
5
Infringement
5
Injunctive Relief
5
Insider Trading
5
Jurisdiction
5
Learned Intermediary
5
Medicare Part B
5
Medtronic
5
Mergers
5
Personalized Medicine
5
Securities Litigation
5
Unfair Competition
5
Unfair or Deceptive Trade Practices
5
USDA
4
Advisory Committee
4
America Invents Act
4
Antitrust Provisions
4
Big Data
4
Boehringer
4
Celebrity Endorsements
4
CGMP
4
Claim Construction
4
Class Certification
4
Classen Immunotherapies
4
Databases
4
Dietary Supplements
4
DNA
4
Durable Medical Equipment
4
Elan Pharmaceuticals
4
Endo Pharmaceuticals
4
EPA
4
FCPA
4
FD&C Act
4
FDA Warning Letters
4
FDASIA
4
Genetic Testing
4
Healthcare Fraud
4
Home Health Care
4
Inadequate Warning
4
Investigational New Drug Application (IND)
4
IRS
4
Kickbacks
4
Laboratory Developed Tests
4
Lanham Act
4
Legislative Committees
4
Licenses
4
Long Term Care Facilities
4
MedPAC
4
Mensing
4
Mental Health
4
Misleading Impressions
4
Monopolization
4
New Legislation
4
No-AG Agreement
4
OPDP
4
Outsourcing
4
OxyContin
4
Patent Trial and Appeal Board
4
Patient Safety
4
Patients
4
PDUFA
4
Permanent Injunctions
4
Pregnancy
4
Regulatory Agenda
4
Samsung
4
Secretary of HHS
4
Settlement Agreements
4
Shareholders
4
Strict Liability
4
Substance Abuse
4
Technology
4
Trade Secrets
4
Transparency
4
UAW
4
User Fees
4
Verification Requirements
4
Wholesale
3
510(k) RTA
3
Acquisitions
3
Allergan v Sandoz
3
Biogen Idec
3
Biopharmaceutical
3
Burden of Proof
3
Center for Drug Evaluation and Research (CDER)
3
CEOs
3
Chevron Deference
3
China
3
Clinical Laboratories
3
Confidential Information
3
Conflicts of Interest
3
Contraceptives
3
Controlled Substances Act
3
Covered Entities
3
Data Protection
3
Daubert Standards
3
Declaratory Relief
3
Disgorgement
3
Dismissals
3
Due Process
3
EHR
3
Employee Benefits
3
Exclusive Dealing Agreements
3
False Statements
3
Federal Register
3
Financial Conduct Authority (FCA)
3
Financial Markets
3
Food and Drug Administration Amendments Act (FDAAA)
3
Food Recalls
3
Foreign Manufacturers
3
Generic
3
Genzyme
3
Google
3
Healthcare Facilities
3
Innovator Liability
3
Inspections
3
Intellectual Property Litigation
3
Internet
3
Interstate Commerce
3
Inventors
3
Investigational New Drug procedures (IND)
3
IRB
3
Kim Kardashian
3
License Agreements
3
Medical Malpractice
3
Medicare Advantage
3
Method Claims
3
Misrepresentation
3
Mutual Pharmaceuticals v Bartlett
3
Notice Provisions
3
On-Sale Bar
3
openFDA
3
Pain Management
3
Patent-Eligible Subject Matter
3
Patient Privacy Rights
3
Premarket Approval Applications
3
Prescription Drug Coverage
3
Private Right of Action
3
PSLRA
3
Public Disclosure
3
Public Health Insurance Marketplace
3
Purple Book
3
Putative Class Actions
3
Quality Control Plan
3
Risk Assessment
3
Risk Management
3
Rule-of-Reason Analysis
3
Rulemaking Process
3
Sealed Records
3
Securities
3
Securities Violations
3
SNDAs
3
Software
3
Strategic Enforcement Plan
3
Subject Matter Jurisdiction
3
Sunshine Act
3
Takeda Pharmaceuticals
3
Tax Credits
3
Telemedicine
3
Twitter
3
Twombly/Iqbal Pleading Standard
3
Veterinary Products
3
Wyeth
2
ACOs
2
All Writs Act
2
American Medical Association
2
Amgen v Sandoz
2
Amicus Briefs
2
AMP v Myriad
2
Animal Drugs
2
Animal Testing
2
Antibiotics
2
Antitrust Injuries
2
Article III
2
AstraZeneca
2
Attorney Generals
2
Attorney-Client Privilege
2
Audits
2
Bifurcation
2
Biometric Information
2
Bristol-Myers Squibb
2
Capital Raising
2
Celltrion
2
Cephalon
2
Chemicals
2
Clear and Convincing Evidence
2
Combination Products
2
Consumer Fraud
2
Controlled Substances
2
Conversion
2
Corporate Integrity Agreement
2
Cosmetics
2
Counterclaims
2
Counterfeit Drugs
2
Crowdfunding
2
Daiichi Sankyo
2
DaimlerChrysler v Bauman
2
Data Breach
2
De Novo Standard of Review
2
Direct to Consumer Sales
2
Disclaimers
2
Diversity Jurisdiction
2
DMEPOS
2
Drug & Alcohol Abuse
2
Duty to Deal
2
Duty to Warn
2
Ethics
2
Evidence
2
Exemptions
2
Expert Witness
2
Failure To Disclose
2
Federal Budget
2
Federal Health Care Programs (FHCP)
2
Federal Question Jurisdiction
2
Financial Sector
2
First Impression
2
First-to-File
2
Fraudulent Joinder
2
FSMA
2
GDUFA
2
General Jurisdiction
2
Gilead Sciences
2
Government Investigations
2
GPOs
2
Guidance Update
2
Hackers
2
Health Insurance Exchanges
2
Health Safety
2
HITECH
2
HIV
2
Human Rights
2
Imports
2
Indictments
2
Induced Infringement
2
Injunctions
2
Inpatient Prospective Payment System (IPPS)
2
Insurance Industry
2
Internal Controls
2
International Arbitration
2
Internet Marketing
2
Investigational Device Exemptions
2
Investment
2
Investors
2
IP License
2
Licensing Rules
2
Manufacturing Defects
2
Marijuana
2
Marketing Authorization Application
2
Medicaid Expansion
2
Medical Reimbursement
2
Medicare Prescription Drug Improvement and Modernization Act (MMA)
2
Mental Health Parity Rule
2
Mobile Apps
2
Mootness
2
National Cancer Moonshot
2
Native American Issues
2
Nike
2
Non-Public Information
2
Obama Administration
2
OCR
2
Omissions
2
Omnibus Guidance
2
Omnicare
2
Omnicare v Laborers District Council
2
Online Advertisements
2
Outsourcing Facilities
2
Over-the-Counter Sales
2
Pay-Per-Click
2
PCORI
2
Personally Identifiable Information
2
Petition for Writ of Certiorari
2
Pharmacist
2
POM Wonderful
2
Post-Grant Review
2
Presidential Elections
2
Price Gouging
2
Publicly-Traded Companies
2
Qualified Small Employer Health Reimbursement Plan (QSEHRAs)
2
RanBaxy
2
Registration Requirement
2
Regulatory Reform
2
Reimbursements
2
Relators
2
Reverse Payments
2
RICO
2
Right to Try
2
Ripeness
2
Safety Precautions
2
Sanctions
2
Sanofi
2
Schering-Plough
2
Scientific Evidence
2
Search Engines
2
Section 503
2
Securities Exchange Act
2
Skilled Nursing Facility
2
Solicitor General
2
Spectrum
2
Standard of Review
2
Stark Law
2
Startups
2
Statute of Limitations
2
Stem cells
2
Stock Drop Litigation
2
Stocks
2
Subsidies
2
Tax Deductions
2
Telehealth
2
Testimony
2
The Common Rule
2
Transfer of Venue
2
TRO
2
Two-Midnight Rule
2
UK
2
User-Generated Content
2
Venture Capital
2
Warner Chilcott
2
Warranties
2
Webinars
2
Written Descriptions
2
Wrongful Death
2
Yates Memorandum
2
Young Lawyers
1
23andMe
1
35 U.S.C. § 271(e)(1)
1
Acceleration
1
Accounting Controls
1
Actos
1
Actual Injuries
1
Addiction Equity Act
1
Additive Manufacturing
1
Administrative Appointments
1
Administrative Authority
1
Administrative Proceedings
1
Admissible Evidence
1
Advance Notice
1
Advisory Opinions
1
Aerospace
1
AHRQ
1
AIDS
1
AIG
1
ALJ
1
All Natural
1
Alzheimer's
1
Amazon
1
Ambulatory Surgery Centers
1
Amended Complaints
1
Amended Regulation
1
Amended Rules
1
Amgen Inc. v Connecticut Retirement Plans
1
Amgen v Apotex
1
Animal Food
1
Animal Health
1
Anti-Monopoly
1
Anti-Retaliation Provisions
1
Anti-Steering Rules
1
Antimicrobials
1
Antitrust Conspiracies
1
App Developers
1
Applicable Manufacturers
1
Applications
1
Appointments Clause
1
Appropriate Equitable Relief
1
Arbitration
1
Article II
1
Artificial Intelligence
1
Asbestos
1
Asbestos Litigation
1
Asia
1
Assignments
1
Attestation Deadlines
1
Australia
1
Automobile Recall
1
Automotive Industry
1
Bank of New York (BNY) Mellon
1
Banking Sector
1
Barclays
1
Bayh-Dole Act
1
Benefit Plan Reimbursements
1
Best Buy
1
Best Management Practices
1
Best Practices
1
Billing
1
Bilski
1
biologic
1
Bipolar Disorder
1
Birth Control Pill
1
Boston Scientific
1
BPCI
1
Brand Name Prescription Drugs
1
Breakthrough Therapy Designation
1
Budget Cuts
1
Business Associates
1
Business Development
1
C&DIs
1
CA Supreme Court
1
CAFC
1
Canadian Intellectual Property Office
1
Cartwright Act
1
Carve Out Provisions
1
Caterpillar
1
CCIIO
1
CERCLA
1
CFPB
1
Chief Compliance Officers
1
Childrens' Motrin
1
Chilling Effect
1
Chip and PIN
1
Cipro
1
Citizen Suits
1
Claim Preclusion
1
Clean Air Act
1
Clean Water Act
1
clear
1
Clearance
1
CLIA
1
Climate Action Plan
1
Clinical Laboratory Testing
1
CLS Bank v Alice Corp
1
CMMI
1
Co-payments
1
COBRA
1
Coca Cola
1
Collateral Estoppel
1
Commerce Clause
1
Commitment Letter
1
Common Law Claims
1
Community Health Systems
1
Compensation & Benefits
1
Compensatory Awards
1
Compensatory Damages
1
Competitive Bidding
1
Complete Genomics
1
Comptroller of the Treasury v Wynne
1
Confidential Documents
1
Conflicting Proposals
1
Congressional Committees
1
Congressional Review Act
1
Consent Decrees
1
Conspiracies
1
Constitutional Challenges
1
Consumer Product Safety Commission (CPSC)
1
Consumer Protection Act
1
Consumers Legal Remedies Act
1
Contamination
1
Contests & Promotions
1
Continuing Medical Education
1
Contraceptive Coverage Mandate
1
Contract Drafting
1
Contributory Infringement
1
Copyright
1
Corporate Misconduct
1
Corporate Officers
1
Corporate Taxes
1
Corrective Actions
1
Corruption
1
Cost-Sharing
1
Costco
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Covered Recipients
1
CPUC
1
CREATE Act
1
Credibility
1
Cross Motions
1
Cross-Border Transactions
1
Cruel & Unusual Punishment
1
Cuozzo Speed Technologies v Lee
1
Customs and Border Protection
1
CVM
1
Cyber Attacks
1
Cyber Threats
1
DaimlerAG
1
Data Breach Plans
1
Data Controller
1
Data Integrity
1
Data Mining
1
Data Security
1
Daubert Ruling
1
De Minimis Claims
1
Debit and Credit Card Transactions
1
Deceptive Intent
1
Defect
1
Defense Strategies
1
Delaware General Corporation Law
1
Delays
1
Department of Transportation (DOT)
1
Department of Veterans Affairs
1
Depositions
1
Derivation Proceeding
1
Device Classification
1
DHS
1
Diagnostic Imaging Services
1
Diagnostic Method
1
Digital Health
1
Direct Infringement
1
Direct Purchasers
1
Dirks v SEC
1
Disability Discrimination
1
Disclosure
1
Discounts
1
Discussion Draft
1
Disruptive Technology
1
Distributors
1
Divided Infringement
1
Document Retention Policies
1
Dodd-Frank
1
DOL
1
Double Jeopardy
1
Drug Testing
1
Drug Treatment
1
DSHEA
1
E-Filing
1
EAR
1
Earn-Outs
1
EEOC
1
Eighth Amendment
1
Electronic Communications
1
Electronic Filing
1
Electronic Health Record Incentives
1
Electronic Records
1
Electronically Stored Information
1
Eleventh Amendment
1
Email
1
Embargo
1
Emerging Markets
1
Employer Group Health Plans
1
Employer Mandates
1
En Banc Review
1
Environmental Policies
1
ERISA
1
Ernst & Young
1
EU-US Privacy Shield
1
European Food Safety Authority (EFSA)
1
Events
1
Evidence Suppression
1
Evidentiary Standards
1
Ex Post Facto Clause
1
Excessive Pricing
1
Excise Tax
1
Executive Orders
1
Expedited FDA Approval
1
Export Controls
1
Exports
1
Extrapolation
1
Failure To State A Claim
1
Fair Notice
1
False Evidence
1
False Press Release
1
Falsified Documents
1
Fast Track Process
1
FBI
1
FCC
1
Federal Rule 12(b)(1)
1
Federal v State Law Application
1
FedEx
1
Fee-for-Service
1
Fee-Shifting
1
Fiduciary Duty
1
Fiduciary Rule
1
Financial Institutions
1
Flame Retardant
1
Flexible Spending Accounts
1
FMCSA
1
Food Allergies
1
Food Labeling
1
Food Poisoning
1
Foreign Corporations
1
Foreign Earned Income
1
Foreign Investment
1
Foreign Tax
1
Foreseeability
1
Form 10-K
1
Form 8-K
1
Forum Shopping
1
Fraud-on-the-Market
1
FRCP 26
1
FSMB
1
FTC Act
1
Funding
1
Genentech
1
General Electric
1
General Services Administration (GSA)
1
General Wellness Devices
1
Genetic Markers
1
Genetic Materials
1
Goldman Sachs
1
Good Cause
1
Good Clinical Practices
1
Goodyear
1
Government Studies
1
Grable Factors
1
Grocery Stores
1
gTLD
1
Guilty Pleas
1
Halliburton v Erica P. John Fund
1
Hazardous Substances
1
Hazardous Waste
1
HCPCS
1
Health & Safety Standard
1
Health Canada
1
Health Care Violations
1
Health IT
1
Health Savings Accounts
1
Healthcare Costs
1
Hedge Funds
1
HELP
1
Hewlett-Packard
1
Hoffman LaRoche
1
Home Depot
1
Homeopathic Remedies
1
Honeybees
1
Hospice
1
Hospital Mergers
1
HRA
1
Human Genes
1
Human Genome Project
1
ICD-10
1
Illegal Tipping
1
Implied Certification
1
Implied Preemption
1
In-Person Exam
1
Incentives
1
Incident Response Plans
1
Income Taxes
1
Indirect Infringement
1
Individual Mandate
1
Inducement
1
Infectious Diseases
1
Information Reports
1
Information Sharing
1
Initial Public Offerings
1
Inpatient Rehab Facilities
1
Integra
1
Inter Partes Reexamination
1
InterDigital Communications v ITC
1
Interest Rate Adjustments
1
Interest Rates
1
InterMune
1
International Harmonization
1
Internet of Things
1
Internet Retailers
1
INTERPOL
1
Interpretive Rule
1
Inventions
1
Investment Adviser
1
Investment Advisers Act of 1940
1
Investment Trust Companies
1
IRF Claim Processing
1
Issue Preclusion
1
JAMA
1
Janus Capital Group
1
Joinder
1
Joint Venture
1
Journalists
1
Judicial Review
1
Jury Awards
1
Jury Trial
1
Justiciable Controversy
1
King v Burwell
1
KPMG
1
LabMD
1
Law Enforcement
1
Leave to Amend
1
Legal History
1
Legal Perspectives
1
License Applications
1
Lipitor
1
Litigation Hold
1
Litigation Privilege
1
Lobbyists
1
Local Ordinance
1
Loss Causation
1
MA Supreme Court
1
Managed Care Contracts
1
Manufacturing Facilities
1
Marijuana Cultivation
1
Marijuana Related Businesses
1
Market Manipulation
1
Market Research
1
MasterCard
1
Material Misrepresentation
1
Material Misstatements
1
MCOs
1
Medical Foods
1
Medical Liability
1
Medical Supplies
1
Medicare Access and CHIP Reauthorization (MACRA)
1
Medicare Modernization Act
1
Memorandum of Understanding
1
Mental Health Initiatives
1
Merrill Lynch v Manning
1
Methane
1
Midnight Rules Relief
1
Minor Children
1
Motion for Reconsideration
1
Motion To Centralize
1
Motion to Remand
1
Motion To Stay
1
Motor Carriers
1
Murder
1
NAD
1
NAFTA
1
Nanomedicine
1
Nanotechnology
1
Natural Products
1
Negligence Per Se
1
Negligent Design
1
New Regulations
1
New Trial
1
Nexus
1
NJ Supreme Court
1
Non-Disclosure Agreement
1
Non-Practicing Entities
1
Notice of Appeal
1
Notifications
1
NPRM
1
Numerosity
1
Nursing Homes
1
OECD
1
OEHHA
1
OFAC
1
Off-Campus Departments
1
Office of Scientific Investigations (OSI)
1
OFVM
1
Oil & Gas
1
ONC
1
Online Platforms
1
Online Reviews
1
Open Enrollment
1
OPPS
1
Opt-Outs
1
Out-of-State Companies
1
Out-of-State Judgments
1
Overpayment
1
Par Pharmaceutical
1
Parallel Claims
1
Partnerships
1
PATENT Act
1
Patent Cooperation Treaty
1
Patent Exhaustion
1
Patent Expiration
1
Patent Filings
1
Patent Portfolios
1
Patent Reform
1
Patent Term Extensions
1
Patent-Misuse
1
Patient Assistance Programs
1
Patient Prospective Payment System
1
Patient-Specific
1
Pay or Play
1
Pay Ratio
1
Pay Ratio Tax
1
Payment Records
1
Payor Contracts
1
Payroll Taxes
1
Pediatrics
1
Penalties
1
Pension Funds
1
Pensions
1
Personal Benefit
1
Personal Care Products
1
Personal Liability
1
Pesticides
1
Pharmaceutical Distribution
1
PHH Corp. v CFPB
1
Planned Parenthood
1
Podcasts
1
Policies and Procedures
1
POM Wonderful v Coca Cola
1
Post-Market Approval
1
Posting Requirements
1
Pradaxa
1
Precision Medicine Initiative (PMI)
1
Presidential Appointments
1
Press Releases
1
Price Transparency
1
Price-Fixing
1
Primary Jurisdiction Doctrine
1
Prior User
1
Prioritized Examination
1
Prison
1
Privacy Laws
1
Privacy Policy
1
Private Placements
1
Privately Held Corporations
1
Privilege Logs
Feedback? Tell us what you think of the new jdsupra.com!